Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism
Author(s) -
Noriko Sato,
Ryu Matsuo,
Fumi Kiyuna,
Kuniyuki Nakamura,
Jun Hata,
Yoshinobu Wakisaka,
Tetsuro Ago,
Masahiro Kamouchi,
Takanari Kitazono
Publication year - 2020
Publication title -
cerebrovascular diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.221
H-Index - 104
eISSN - 1421-9786
pISSN - 1015-9770
DOI - 10.1159/000510773
Subject(s) - medicine , embolic stroke , stroke (engine) , embolism , intracranial embolism , cardiology , stroke risk , ischemic stroke , ischemia , mechanical engineering , engineering
This study aimed to determine whether use of oral anticoagulants (OACs) was associated with a reduced risk of recurrent stroke compared with use of antiplatelets (APs) in patients with embolic stroke of undetermined source (ESUS) having no potential source of embolism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom